Swedbank AB Lowers Stock Holdings in Masimo Corporation $MASI

Swedbank AB decreased its position in shares of Masimo Corporation (NASDAQ:MASI) by 11.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 59,500 shares of the medical equipment provider’s stock after selling 8,000 shares during the quarter. Swedbank AB owned approximately 0.11% of Masimo worth $7,739,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Global Retirement Partners LLC purchased a new position in shares of Masimo during the 4th quarter valued at $27,000. Torren Management LLC purchased a new position in shares of Masimo during the 4th quarter valued at $35,000. Smartleaf Asset Management LLC lifted its stake in shares of Masimo by 80.0% during the 3rd quarter. Smartleaf Asset Management LLC now owns 306 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 136 shares in the last quarter. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Masimo during the 4th quarter valued at $44,000. Finally, Advisory Services Network LLC purchased a new position in shares of Masimo during the 3rd quarter valued at $46,000. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Analysts Set New Price Targets

MASI has been the topic of a number of analyst reports. Wells Fargo & Company upgraded shares of Masimo to a “hold” rating in a research note on Wednesday, March 18th. Stifel Nicolaus set a $180.00 target price on shares of Masimo in a research note on Tuesday, February 17th. Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Wolfe Research cut shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 19th. Finally, BTIG Research cut shares of Masimo from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 18th. Nine research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $180.40.

Masimo Stock Down 0.1%

Shares of MASI stock opened at $178.67 on Wednesday. The stock has a market cap of $9.36 billion, a P/E ratio of -16.95, a PEG ratio of 1.81 and a beta of 1.13. Masimo Corporation has a 52 week low of $125.94 and a 52 week high of $179.00. The company has a quick ratio of 1.45, a current ratio of 2.68 and a debt-to-equity ratio of 0.56. The company’s fifty day simple moving average is $178.25 and its two-hundred day simple moving average is $157.64.

Masimo Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.